These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16391853)

  • 41. Pathobiology of CD30+ cutaneous T-cell lymphomas.
    Kadin ME
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay.
    Yagi H; Seo N; Ohshima A; Itoh T; Itoh N; Horibe T; Yoshinari Y; Takigawa M; Hashizume H
    Am J Surg Pathol; 2006 Sep; 30(9):1111-9. PubMed ID: 16931956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immuno-intervention in cutaneous lymphomas].
    Dummer R; Heinzerling L; Schmid MH; Burg G
    Praxis (Bern 1994); 2000 Sep; 89(37):1471-6. PubMed ID: 11037619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses.
    Chang KC; Huang GC; Jones D; Lin YH
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6666-72. PubMed ID: 18006767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous folliculitis.
    Arai E; Shimizu M; Hirose T
    Hum Pathol; 2005 May; 36(5):505-11. PubMed ID: 15948117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma.
    Lozzi GP; Massone C; Citarella L; Kerl H; Cerroni L
    Am J Dermatopathol; 2006 Feb; 28(1):9-12. PubMed ID: 16456318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T-cell primary cutaneous lymphomas. A clinicopathological and immunohistochemical study.
    Caruntu ID; Mardari V; Radulescu D; Chirana A; Cozma L; Taranu T; Dobrescu G
    Pol J Pathol; 2007; 58(4):259-65. PubMed ID: 18459460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation?
    Frater JL; Kling CW; Obadiah JM; Gardner LJ; Grosso LE; Resh B; Hurley MY
    J Cutan Pathol; 2006 Jun; 33(6):437-42. PubMed ID: 16776720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of immunohistochemistry in the diagnosis of cutaneous lymphoma.
    Smoller BR
    Adv Dermatol; 1997; 13():207-34. PubMed ID: 9551145
    [No Abstract]   [Full Text] [Related]  

  • 50. Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells.
    Gerlini G; Hefti HP; Kleinhans M; Nickoloff BJ; Burg G; Nestle FO
    J Invest Dermatol; 2001 Sep; 117(3):576-82. PubMed ID: 11564162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod.
    Wollenberg A; Wen S; Bieber T
    Cytometry; 1999 Oct; 37(2):147-55. PubMed ID: 10486527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
    Mao X; Orchard G; Russell-Jones R; Whittaker S
    Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphomatoid papulosis: a cutaneous T-cell pseudolymphoma.
    Burg G; Hoffmann-Fezer G; Nikolowski J; Schmoeckel C; Braun-Falco O; Stünkel K
    Acta Derm Venereol; 1981; 61(6):491-6. PubMed ID: 6177159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory cells in the formation of tumor-related sarcoid reactions.
    Kurata A; Terado Y; Schulz A; Fujioka Y; Franke FE
    Hum Pathol; 2005 May; 36(5):546-54. PubMed ID: 15948122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clusterin expression in cutaneous CD30-positive lymphoproliferative disorders and their histologic simulants.
    Olsen SH; Ma L; Schnitzer B; Fullen DR
    J Cutan Pathol; 2009 Mar; 36(3):302-7. PubMed ID: 19220628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Langerhans' cells in normal and eczematous dermatitis skin by CD1a protein immunohistochemistry: preliminary findings.
    Hussein MR
    J Cutan Pathol; 2008 Jun; 35(6):554-8. PubMed ID: 18312440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD1a positive putative tumour infiltrating dendritic cells in human breast cancer.
    Coventry BJ
    Anticancer Res; 1999; 19(4B):3183-7. PubMed ID: 10652609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides.
    Fujimura T; Okuyama R; Ito Y; Aiba S
    Br J Dermatol; 2008 Jun; 158(6):1256-63. PubMed ID: 18363755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
    Kempf W
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.